View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Carole Braudeau
  • Carole Braudeau

Credit Morning 03/26/2026

Webuild: Termination of Trojena project but positive momentum should continue|Emeria: no change in the situation following the 2025 earnings call|Asmodee acquires ATM Gaming for € 180m|Kantar: better outlook in 2026, Bain mulls an exit without specifying a timeframe|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 26/03/2026

Webuild: Termination of Trojena project but positive momentum should continue|Emeria : une situation inchangée après le call des résultats 2025|Asmodee acquiert ATM Gaming pour 180 m EUR|Kantar : meilleures perspectives en 2026, Bain envisage une sortie dans donner d’horizon précis|

Research Department
  • Research Department

IBERIAN DAILY 26 MARCH (ANÁLISIS BANCO SABADELL)

NEWS SUMMARY: ELECTRICITY SECTOR, GRIFOLS, INDRA, MERLÍN PROPERTIES, VIDRALA. Markets continue to rally European stock markets continued to recover, underpinned by the US proposal for a ceasefire in the Middle East, although the gains were reeled in slightly after Iran rejected the proposal. In the STOXX 600, all the sectors were in green, with Basic Materials and Financial Services leading the way, whereas defensive sectors like Household Goods and Telecoms rose the least. On the macro side, ...

Carole Braudeau
  • Carole Braudeau

Credit Morning 03/25/2026

Maxeda completes recapitalisation and debt restructuring|Emeria: Q4 2025 results still fall far short|Grifols mulls an IPO of its Biopharma business in the US|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 25/03/2026

Maxeda : finalisation des opérations de recapitalisation et de restructuration de la dette|Emeria : résultats T4 2025 encore très insuffisants|Grifols envisage une cotation de son activité Biopharma aux Etats-Unis|

 PRESS RELEASE

Grifols Shares Results From its Chronos Platform Identifying Early Mol...

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson’s Disease Chronos‑PD shows that biological changes associated with Parkinson’s disease (PD) can emerge up to 12 years before clinical diagnosisUncovered reproducible early molecular signals and distinct molecular patterns in PD, supporting future efforts in patient stratification and precision medicine researchChronos is part of a broad Grifols program to find early disease biomarkers leveraging more than 100 million proprietary plasma samples connected to real-world data on thousa...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 16/03/2026

Unicredit lance une OPE sur Commerzbank|

Carole Braudeau
  • Carole Braudeau

Credit Morning 03/16/2026

Unicredit launches a takeover bid for Commerzbank|

Carole Braudeau
  • Carole Braudeau

Credit Morning 02/27/2026

INEOS Quattro: conference call comments|NIH: improvement in certain indicators in H2, but still little visibility on M&A|Ardagh Group surprises with strong increase in glass EBITDA in Q4|Clariane : Satisfactory 2025 results thanks to strong recovery in H2 25 and B2/B+ ratings assigned by Moody’s and S&P|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 27/02/2026

INEOS Quattro: conference call comments|NIH : amélioration de certains indicateurs au S2 mais toujours peu de visibilité sur le M&A|Ardagh Group surprend avec une forte hausse de l’EBITDA verre au T4|Clariane : Résultats 2025 satisfaisants grâce à un bon rattrapage au 2nd semestre et ratings B2/B+ attribués par Moody’s et S&P|

Jamila El Bougrini ... (+2)
  • Jamila El Bougrini
  • Thibaut Voglimacci-Stephanopoli
Research Department
  • Research Department

IBERIAN DAILY 27 FEBRUARY + 4Q'25 RESULTS. PREVIEWS (ANÁLISIS BANCO SA...

NEWS SUMMARY: ACCIONA, ACCIONA ENERGÍA, ACERINOX, AMADEUS, CELLNEX, COLONIAL, ELECTRICITY SECTOR, FCC, GLOBAL DOMINION, GRIFOLS, IAG, MERLIN, OHLA, REDEIA, SACYR, SOLARIA, VISCOFAN. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 4Q’25 results to be released over the coming days in Spain. Doubts continue to plague Nasdaq, but software rallies after harsh punishment European s...

Carole Braudeau
  • Carole Braudeau
Carole Braudeau
  • Carole Braudeau

Morning Crédit 17/02/2026

Rating corporate relevé à B1 par Moody’s|

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch